Ontario aims to widely distribute naloxone kits, a medication that can counter the effects of an opioid overdose, to combat the growing impacts of the opioid crisis through the Ontario Naloxone Program and the Ontario Naloxone Program for Pharmacies.
This study aimed to measure the uptake of naloxone through both the pharmacy- and community- based programs in Ontario and to assess if distribution benchmarks were achieved.
Access the full report and associated resources:
